These compounds may interact with:
Cytochrome P450 2C19
Potentially involved in: melanoma; carcinoma; coronary artery disease; gastroesophageal reflux disease; peptic ulcer disease; cerebrovascular disease; esophagitis; epilepsy; aspergillosis; cancer; gastritis; major depressive disorder; transient cerebral ischemia; liver disease; cardiovascular diseases; mental depression; depressive disorder; kidney failure, chronic; prostatic neoplasms; thrombosis
Disease data sourced from Pharos.